KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Accumulated Expenses (2017 - 2025)

Novartis Ag's Accumulated Expenses history spans 9 years, with the latest figure at $1.0 billion for Q4 2025.

  • On a quarterly basis, Accumulated Expenses rose 518.34% to $1.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.0 billion, a 518.34% increase, with the full-year FY2025 number at $1.0 billion, up 518.34% from a year prior.
  • Accumulated Expenses hit $1.0 billion in Q4 2025 for Novartis Ag, up from $169.0 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for NVS hit a ceiling of $1.1 billion in Q4 2022 and a floor of $116.0 million in Q4 2023.
  • Historically, Accumulated Expenses has averaged $421.9 million across 5 years, with a median of $182.0 million in 2022.
  • Biggest five-year swings in Accumulated Expenses: skyrocketed 733.86% in 2022 and later tumbled 89.05% in 2023.
  • Tracing NVS's Accumulated Expenses over 5 years: stood at $127.0 million in 2021, then surged by 733.86% to $1.1 billion in 2022, then tumbled by 89.05% to $116.0 million in 2023, then skyrocketed by 45.69% to $169.0 million in 2024, then soared by 518.34% to $1.0 billion in 2025.
  • Business Quant data shows Accumulated Expenses for NVS at $1.0 billion in Q4 2025, $169.0 million in Q4 2024, and $116.0 million in Q4 2023.